SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ:QDEL), a leader in point-of-care (POC) rapid diagnostic tests, today announced recent initiatives to educate and inform the healthcare community ...

SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

When determining winners and losers in the 2020-2021 stock market, it is important not to overlook the companies that supply testing kits for COVID-19. The Quidel Corporation (QDEL) manufactures rapid ...

Quidel is a highly profitable medical diagnostic company. It has now diversified into Covid testing. The company has both the scale and financial capacity to take on the challenge to produce high ...

Forbes contributors publish independent expert analyses and insights. Quidel, a company that makes diagnostic products for infectious diseases and other conditions, has been the biggest winner in our ...

After a blockbuster two years bolstered by sales of its multiple COVID-19 diagnostics, Quidel is looking for a way to reinvest that windfall back into the business—and seems to have found it in the ...

Quidel's incremental gains in revenue have been derived significantly from COVID-19, which generated 78.9% of revenues for Q3. Gross margin grew over 2000 bp for Q3, driven by the low COGS and ...

Rival Abbott is looking to become the dominant player in the coronavirus test arena. Quidel fell the most because its COVID-19 test, the Sofia SARS Antigen FIA, is in the same class as Abbott's ...

A few months back we discussed that Quidel stock looks undervalued at levels of around $108, based on the testing demand and the company’s future growth prospects. QDEL stock has since rallied 36% to ...

Quidel hasn't announced many notable COVID-19 deals in the past few months, so demand could again be low this quarter. Quidel stock is volatile, and its shares could continue to tumble this year if ...

WASHINGTON (AP) — Speed and accuracy are key features when screening for coronavirus. Quidel Corp. is one of a handful of U.S. companies authorized to sell a rapid test for COVID-19, yielding results ...